- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07631663
Satiety Evaluation of Mature Okra Flour-incorporated Biscuit (MOFB)
Evaluating the Impact of Mature Okra Flour-Incorporated Biscuits (MOFB) on Perceived Satiety Through the Satiety Labeled Intensity Magnitude (SLIM) Scale and Metabolomic Approach
This study aims to evaluate whether eating biscuits made with mature okra flour can help young adults feel fuller (enhance satiety) and change certain blood markers compared to eating standard biscuits.
Mature okra is a nutrient-dense agricultural by-product that is often discarded due to its tough texture. For this study, mature okra pods are dried and ground into a flour, which is then used to replace 10% of the wheat flour in a custom biscuit formulation.
Participants will take part in a single-blind, randomised trial where they will consume either the okra-incorporated biscuits or the standard control biscuits on separate occasions. Researchers will measure participants' perceived fullness over 165 minutes using a visual rating scale. Blood samples will also be collected at specific intervals during this time to evaluate blood glucose levels, appetite-related hormones, and metabolic responses.
연구 개요
상세 설명
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Chee Yee Tan
- 전화번호: +60134904250
- 이메일: cheeyee721@gmail.com
연구 연락처 백업
- 이름: Mohd Redzwan Sabran, PhD
- 전화번호: +60397692766
- 이메일: mohdredzwan@upm.edu.my
연구 장소
-
-
Selangor
-
Serdang, Selangor, 말레이시아, 43400
- 모병
- Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM)
-
연락하다:
- Chee Yee Tan
- 전화번호: +60134904250
- 이메일: cheeyee721@gmail.com
-
수석 연구원:
- Mohd Redzwan Sabran, PhD
-
부수사관:
- Chee Yee Tan
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Young adults aged between 18 and 39 years.
- Normal Body Mass Index (BMI).
Exclusion Criteria:
- Smokers.
- Pregnant or lactating women.
- Individuals with daily medication prescriptions for chronic metabolic conditions, cardiovascular management, or hormonal regulation.
Use of daily medications/supplements that influence appetite regulation, metabolic signalling, or systemic metabolomic profiles, including:
- Hormonal contraceptives, glucocorticoids, and oral/injectable anti-obesity medications (e.g., GLP-1 agonists).
- Antihypertensives and lipid-lowering agents (statins).
- Chronic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
- Daily fibre supplements.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Mature Okra Flour-incorporated Biscuit (MOFB) Group
Young adult participants assigned to this group will consume the functional biscuit formulation incorporated with mature okra flour.
Perceived satiety, metabolomic profiles, and appetite signalling will be assessed post-ingestion.
|
Standard biscuit formulation manufactured where 10% of the wheat flour is substituted with mature okra flour, designed to enhance the nutritional profile while maintaining acceptable sensory scores.
|
|
활성 비교기: Control Biscuit Group
Young adult participants assigned to this group will consume the standard control biscuit formulation made with 100% wheat flour.
Perceived satiety, metabolomic profiles, and appetite signalling will be assessed post-ingestion.
|
Standard biscuit formulation manufactured using 100% wheat flour, designed to match the sensory profile and appearance of the experimental biscuit without the inclusion of mature okra flour.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Satiety Response
기간: Baseline (0 minutes) and post-consumption at 15, 45, 75, 105, 135, and 165 minutes
|
The satiety response after biscuit consumption will be determined by the Satiety Labeled Intensity Magnitude (SLIM) scale.
The SLIM scale consists of a 100mm vertical line with labelled phrases to indicate satiety: "greatest imaginable fullness", "extremely full", "very full", "moderately full", "slightly full", "neither hungry nor full", "slightly hungry", "moderately hungry", "very hungry", and "extremely hungry", and "greatest imaginable hunger".
The first satiety survey is filled before breakfast (time 0), and the remaining surveys at 15, 45, 75, 105, 135 and 165 min later.
|
Baseline (0 minutes) and post-consumption at 15, 45, 75, 105, 135, and 165 minutes
|
|
Change in Plasma Insulin Concentration
기간: Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
Plasma concentration of insulin will be measured using an enzyme-linked immunosorbent assay (ELISA) kit.
This metric evaluates metabolic responses to the biscuit interventions.
|
Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
|
Change in Active Glucagon-Like Peptide-1 (GLP-1) Concentration
기간: Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
Plasma concentration of active GLP-1 will be measured using an enzyme-linked immunosorbent assay (ELISA) kit.
This metric evaluates anorexigenic hormone responses to the biscuit interventions.
|
Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
|
Change in Plasma Peptide YY (PYY3-36) Concentration
기간: Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
Plasma concentration of PYY3-36 will be measured using an enzyme-linked immunosorbent assay (ELISA) kit.
This metric evaluates anorexigenic hormone responses to the biscuit interventions.
|
Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
|
Change in Plasma Cholecystokinin (CCK) Concentration
기간: Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
Plasma concentration of CCK will be determined using a radioimmunoassay (RIA) kit.
This metric evaluates anorexigenic hormone responses to the biscuit interventions.
|
Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
|
Change in Active Ghrelin Concentration
기간: Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
Plasma concentration of active ghrelin will be measured using an enzyme-linked immunosorbent assay (ELISA) kit.
This metric evaluates orexigenic hormone responses to the biscuit interventions.
|
Fasting state (0 minutes), 75 minutes, and 165 minutes post-consumption
|
|
Changes in Metabolite Profiles
기간: Fasting state (0 minutes) and 165 minutes post-consumption
|
For metabolomic analysis, the blood samples will be taken in the fasting state (0 min) and after the last satiety survey (165 min).
Metabolites will be quantified by Liquid Chromatography-Mass Spectrometry (LC-MS) analysis, and the serum samples will be prepared according to In Vitro Diagnostics Research (IVDr) standard operating procedures.
|
Fasting state (0 minutes) and 165 minutes post-consumption
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Blood Glucose Response
기간: Baseline (0 minutes) and post-consumption at 15, 45, 75, 105, 135, and 165 minutes
|
The capillary blood glucose will be measured using the finger-prick method during the fasting state (time 0), and at 15, 45, 75, 105, 135 and 165 min later.
|
Baseline (0 minutes) and post-consumption at 15, 45, 75, 105, 135, and 165 minutes
|
|
Ad Libitum Energy Intake at a Subsequent Meal
기간: At the end of the satiety evaluation session (165 minutes post-biscuit consumption)
|
Following the 165-minute satiety evaluation session, participants will be served an ad libitum meal consisting of fried rice and requested to consume as much as they want until comfortably full.
The weight of the food consumed will be calculated by subtracting the remaining food weight from the initial served weight using a digital weighing scale (accurate to 1.0 g).
Total energy intake will be calculated by multiplying the weight of the food consumed by the specific caloric content of the fried rice (expressed in kilocalories).
|
At the end of the satiety evaluation session (165 minutes post-biscuit consumption)
|
공동 작업자 및 조사자
수사관
- 연구 의자: Mohd Redzwan Sabran, PhD, Universiti Putra Malaysia
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- JKEUPM-2025-1085
- GP-IPS/2024/9813100 (기타 보조금/기금 번호: Universiti Putra Malaysia)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .